FDA grants priority review to Merck’s new biologics license application for V116
V116 is an investigational, 21-valent pneumococcal conjugate vaccine specifically designed to protect adults
V116 is an investigational, 21-valent pneumococcal conjugate vaccine specifically designed to protect adults
Leading USA based genetic testing brand officially enters the Indian market
Cresemba is the only azole antifungal therapy approved for pediatric patients as young as one affected by these serious, potentially life-threatening infections
Express Scripts to add Zepbound to National Preferred Formulary
The esteemed duo perfectly embody the brand's core values of family, love, and the special bond we share with our pets
STABILIZE-CKD and DIALIZE-Outcomes trials are part of the CRYSTALIZE evidence programme
Carmot Therapeutics’s R&D portfolio of clinical stage incretins has great potential to treat obesity, diabetes and potentially other diseases
A new GSK survey shows a large number of adults do not understand how shingles may be triggered
Subscribe To Our Newsletter & Stay Updated